Essential Drug System Implementation Faces Regional Discrepancies, Delays
This article was originally published in PharmAsia News
Executive SummaryChina's recent 2010 National Health Conference put forward plans to expand implementation of provincial essential drug systems from 30 percent to 60 percent this year, but important questions still linger
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.